Breaking News Instant updates and real-time market news.

ZNGA

Zynga

$3.94

-0.005 (-0.13%)

09:19
08/09/18
08/09
09:19
08/09/18
09:19

Barclays starts Zynga with Underweight rating, $3.70 price target

Barclays analyst Ryan Gee initiated coverage of Zynga with an Underweight rating and $3.70 price target. At 13 times 2019 EBITDA expectations, the stock already reflects solid future execution, Gee tells investors in a research note. He believes that for Zynga to sustain its "premium" multiple, the company must further close the "wide margin gap" relative to peers by accelerating bookings or greatly rationalizing operating expenditures. Much of the "easy" work to grow margins has already happened, Gee contends. He sees more upside elsewhere in the Internet/Gaming group.

ZNGA Zynga
$3.94

-0.005 (-0.13%)

05/30/18
BARD
05/30/18
NO CHANGE
Target $4
BARD
Neutral
Zynga deal consistent with previously laid out 'live' strategy, says Baird
After Zynga announced it had acquired privately-held mobile game maker Gram Games, Baird analyst Colin Sebastian said the deal is consistent with the company's previously laid out strategy around live services. He sees Zynga cross-selling titles across the respective gamer bases, creating customer acquisition efficiencies and improved monetization, and has confidence in Zynga management's recent execution track record, Sebastian tells investors. He keeps a Neutral rating and $4 price target on Zynga shares.
05/31/18
PIPR
05/31/18
NO CHANGE
Target $5
PIPR
Overweight
Zynga acquisition adds growing revenue stream, says Piper Jaffray
Piper Jaffray analyst Michael Olson says Zynga's $250M acquisition of Gram Games brings a profitably growing revenue stream. Gram brings a development team that has been responsible for several solid titles, including the company's most successful title, Merge Dragons, Olson tells investors in a research note. He believes Zynga is "building a pipeline of new titles and has several potential growth drivers." The analyst maintains an Overweight rating on the shares with a $5 price target.
05/31/18
BNCH
05/31/18
NO CHANGE
Target $5
BNCH
Buy
Zynga price target raised to $5 after Gram Games deal at Benchmark
Benchmark analyst Mike Hickey raised his price target on Zynga to $5 from $4.36 and reiterated his Buy rating after the company announced the acquisition of mobile game developer Gram Games. He contends the "swimmingly boring" deal should drive considerable EBITDA growth while leveraging Zynga's strength in established genres. Hickey also believes this and other potential M&A along with new game launches should help drive bookings growth and continued EBITDA acceleration.
08/01/18
BARD
08/01/18
NO CHANGE
Target $4
BARD
Neutral
Zynga Q2 results roughly in line, says Baird
Baird analyst Colin Sebastian kept his Neutral rating and $4 price target on Zynga after its Q2 results. The analyst notes that the 12% rise in bookings to $233.9M was above consensus of $230.4M thanks to continued growth in Mobile, while adjusted EBITDA of $43.6M was above consensus of about $40M. Sebastian adds that Zynga's "mobile momentum of forever franchises continues to increase, while cost efficiencies drive significant margin improvements" for the company.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
09/26/18
09/26
10:16
09/26/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$151.89

2.98 (2.00%)

10:15
09/26/18
09/26
10:15
09/26/18
10:15
Hot Stocks
IBM rises after UBS says buy on AI potential, low public cloud exposure »

In a research note to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

10:15
09/26/18
09/26
10:15
09/26/18
10:15
General news
Breaking General news story  »

Week of 9/21 EIA…

SVMK

SurveyMonkey

$0.00

(0.00%)

10:13
09/26/18
09/26
10:13
09/26/18
10:13
Syndicate
SurveyMonkey indicated to open at $20, IPO priced at $12 »

SurveyMonkey (SVMK)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BBVA

Banco Bilbao

$6.55

-0.035 (-0.53%)

10:12
09/26/18
09/26
10:12
09/26/18
10:12
Hot Stocks
Banco Bilbao designates CEO Carlos Torres Vila as next chairman »

The board BBVA approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

F

Ford

$9.37

-0.025 (-0.27%)

, VLKAY

Volkswagen

$0.00

(0.00%)

10:10
09/26/18
09/26
10:10
09/26/18
10:10
Periodicals
Ford expands partnership talks with VW, Mahindra to cut costs, Reuters reports »

Ford (F) CEO Jim Hackett…

F

Ford

$9.37

-0.025 (-0.27%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 02

    Oct

SQ

Square

$94.76

-0.64 (-0.67%)

10:10
09/26/18
09/26
10:10
09/26/18
10:10
Options
Heavy trading in Square weekly options as shares fall from record highs »

Heavy trading in Square…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 26

    Nov

ETTX

Entasis Therapeutics

$0.00

(0.00%)

10:03
09/26/18
09/26
10:03
09/26/18
10:03
Syndicate
Entasis Therapeutics opens at $13.45, IPO priced at $15.00 per share »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WOR

Worthington

$42.88

-3.39 (-7.33%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Worthington falls -7.4% »

Worthington is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

GPRO

GoPro

$7.25

0.62 (9.35%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Options
Active trading in GoPro weekly options as shares spike »

Active trading in GoPro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATU

Actuant

$27.10

-2.65 (-8.91%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Actuant falls -7.9% »

Actuant is down -7.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PES

Pioneer Energy

$3.13

-0.325 (-9.42%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Pioneer Energy falls -8.1% »

Pioneer Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BFR

BBVA Banco Frances

$12.83

0.63 (5.16%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
BBVA Banco Frances rises 5.4% »

BBVA Banco Frances is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRS

Irsa Inversiones y Representaciones SA

$18.00

1.18 (7.02%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Irsa Inversiones y Representaciones SA rises 7.3% »

Irsa Inversiones y…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBD

Care Concepts I, Inc.

$24.22

(0.00%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Care Concepts I, Inc. rises 6.6% »

Care Concepts I, Inc. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$7.25

0.62 (9.35%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
GoPro rises following analyst upgrade on 'compelling' products »

Shares of GoPro (GPRO)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMNY

Helios and Matheson

$0.02

-0.0015 (-8.06%)

, AMC

AMC Entertainment

$20.05

0.175 (0.88%)

09:56
09/26/18
09/26
09:56
09/26/18
09:56
Hot Stocks
Helios and Matheson sinks as AMC's Stubs A-List surpasses 380,000 members »

Shares of MoviePass…

HMNY

Helios and Matheson

$0.02

-0.0015 (-8.06%)

AMC

AMC Entertainment

$20.05

0.175 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 13

    Nov

SCG

Scana

$36.25

0.96 (2.72%)

, ALXN

Alexion

$134.40

5.4 (4.19%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Options
Early notable gainers among liquid option names on September 26th »

Notable gainers among…

SCG

Scana

$36.25

0.96 (2.72%)

ALXN

Alexion

$134.40

5.4 (4.19%)

VIAB

Viacom

$33.80

1.32 (4.06%)

NLSN

Nielsen

$28.00

0.795 (2.92%)

GE

General Electric

$11.42

0.15 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 18

    Feb

ABBV

AbbVie

$94.50

0.72 (0.77%)

, VRTX

Vertex

$184.11

1.54 (0.84%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Xu,…

ABBV

AbbVie

$94.50

0.72 (0.77%)

VRTX

Vertex

$184.11

1.54 (0.84%)

ACER

Acer Therapeutics

$30.55

(0.00%)

BHVN

Biohaven Pharmaceutical

$37.47

(0.00%)

CELG

Celgene

$88.38

0.82 (0.94%)

EXEL

Exelixis

$17.38

0.19 (1.11%)

PTLA

Portola Pharmaceuticals

$28.27

0.57 (2.06%)

BMY

Bristol-Myers

$62.20

0.38 (0.61%)

BIIB

Biogen

$342.79

1.21 (0.35%)

AMGN

Amgen

$208.06

1.59 (0.77%)

BLUE

Bluebird Bio

$141.90

(0.00%)

ONCE

Spark Therapeutics

$57.63

0.07 (0.12%)

LOXO

Loxo Oncology

$164.55

-2.25 (-1.35%)

RCKT

Rocket Pharmaceuticals

$25.11

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 04

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

  • 25

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 27

    Nov

  • 01

    Dec

  • 31

    Dec

  • 14

    Jan

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Subcommittee on…

KO

Coca-Cola

$45.79

0.105 (0.23%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Senate Environment and Public Works Committee to hold a hearing »

The Committee holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 30

    Oct

TWTR

Twitter

$28.85

-0.26 (-0.89%)

, T

AT&T

$33.80

0.04 (0.12%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Senate Commerce, Science & Transportation Committee to hold a hearing »

The Committee holds a…

TWTR

Twitter

$28.85

-0.26 (-0.89%)

T

AT&T

$33.80

0.04 (0.12%)

GOOG

Alphabet

$1,180.39

-4.17 (-0.35%)

CHTR

Charter

$325.69

2.3 (0.71%)

AMZN

Amazon.com

$1,964.97

-9.53 (-0.48%)

AAPL

Apple

$221.94

-0.25 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 04

    Oct

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 07

    Nov

  • 12

    Nov

  • 03

    Mar

AVHI

A.V. Homes

$21.48

(0.00%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
A.V. Homes to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 15

    Nov

PFE

Pfizer

$44.07

0.27 (0.62%)

, AMGN

Amgen

$208.06

1.59 (0.77%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Drug Information Association to hold a virtual conference »

Biosimilar Reimbursement…

PFE

Pfizer

$44.07

0.27 (0.62%)

AMGN

Amgen

$208.06

1.59 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 30

    Oct

  • 09

    Nov

PTE

PolarityTE

$20.11

-1 (-4.74%)

, COOL

Ticker changed to PTE

$0.00

(0.00%)

09:53
09/26/18
09/26
09:53
09/26/18
09:53
Periodicals
Violations found by FDA at PolarityTE facility, Capitol Forum says »

The FDA send a Form 483…

PTE

PolarityTE

$20.11

-1 (-4.74%)

COOL

Ticker changed to PTE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.